SQZ Biotechnologies Company
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SQZ Biotechnologies Company generated cash of -$83,549,000, which is less than the previous year. Cash used in financing activities reached the amount of $4,233,000 last year. Net change in cash is therefore -$79,804,000.
Cash Flow
| 2018 | 21.09M | -36.96M | 68.11M |
|---|---|---|---|
| 2019 | -33.49M | -12.84M | 26.03M |
| 2020 | -43.15M | 57.82M | 116.41M |
| 2021 | -82.13M | -613K | 55.90M |
| 2022 | -83.54M | -488K | 4.23M |
SQZ Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 145.81M | 172.66M | 41.57M | 61.87M | 9.62M |
Operating activities | |||||
Net income | -79.46M | -68.74M | -50.52M | -32.20M | -19.25M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 11.68M | 11.03M | 10.94M | 4.35M | 1.06M |
Stock-based compensation expense | 8.40M | 8.50M | 3.60M | 2.10M | 590K |
| Deferred income tax benefit | 8.40M | 8.50M | 3.60M | 2.10M | 590K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 3M | -1.10M | -18K | -1.00M | -365K |
Inventories | 0 | -8.70M | -12.10M | -2.63M | 2.36M |
Accounts payable | -1.42M | 1.07M | 100K | 1.70M | 434K |
Cash generated by operating activities | -83.54M | -82.13M | -43.15M | -33.49M | 21.09M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | -115.88M | -74.90M |
Investments In Property Plant And Equipment | -522K | -613K | -1.17M | -2.16M | 39.25M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -488K | -613K | 57.82M | -12.84M | -36.96M |
Financing activities | |||||
Common Stock Issued | 4.06M | 56.4M | 75.49M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 29K | 103K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 4.23M | 55.90M | 116.41M | 26.03M | 68.11M |
Net Change In Cash | -79.80M | -26.84M | 131.08M | -20.30M | 52.25M |
Cash at end of period | 66.01M | 145.81M | 172.66M | 41.57M | 61.87M |
| Data source | Data source | Data source |